Veru Inc (VERU)
1.275
0.00 (0.00%)
USD |
NASDAQ |
Apr 23, 16:00
1.29
+0.02
(+1.18%)
After-Hours: 19:27
Veru Cash from Investing (TTM): 6.620M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 6.620M |
September 30, 2023 | 6.334M |
June 30, 2023 | 5.398M |
March 31, 2023 | 1.827M |
December 31, 2022 | 1.784M |
September 30, 2022 | 4.267M |
June 30, 2022 | 4.194M |
March 31, 2022 | 1.648M |
December 31, 2021 | 1.828M |
September 30, 2021 | 14.62M |
June 30, 2021 | 14.81M |
March 31, 2021 | 14.94M |
December 31, 2020 | 14.91M |
September 30, 2020 | -0.1058M |
June 30, 2020 | -0.107M |
March 31, 2020 | -0.1626M |
December 31, 2019 | -0.1303M |
September 30, 2019 | -0.1085M |
June 30, 2019 | -0.0779M |
March 31, 2019 | -0.0494M |
December 31, 2018 | -0.0487M |
September 30, 2018 | -0.0507M |
June 30, 2018 | -0.0186M |
March 31, 2018 | -0.0088M |
December 31, 2017 | -0.0267M |
Date | Value |
---|---|
September 30, 2017 | -0.0904M |
June 30, 2017 | -0.1224M |
March 31, 2017 | -0.0871M |
December 31, 2016 | -0.0691M |
September 30, 2016 | -0.0064M |
June 30, 2016 | -0.0113M |
March 31, 2016 | -0.1111M |
December 31, 2015 | -0.1361M |
September 30, 2015 | -0.1354M |
June 30, 2015 | -0.138M |
March 31, 2015 | -0.0404M |
December 31, 2014 | -0.0177M |
September 30, 2014 | -0.0973M |
June 30, 2014 | -0.0996M |
March 31, 2014 | -0.1254M |
December 31, 2013 | -0.3152M |
September 30, 2013 | -0.3022M |
June 30, 2013 | -0.502M |
March 31, 2013 | -0.7041M |
December 31, 2012 | -0.6897M |
September 30, 2012 | -0.6542M |
June 30, 2012 | -0.4528M |
March 31, 2012 | -0.229M |
December 31, 2011 | -0.0538M |
September 30, 2011 | -0.0463M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.1626M
Minimum
Mar 2020
14.94M
Maximum
Mar 2021
4.868M
Average
1.828M
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
EyePoint Pharmaceuticals Inc | -3.315M |
Regeneron Pharmaceuticals Inc | -3.185B |
Bio-Path Holdings Inc | -- |
Aileron Therapeutics Inc | 16.20M |
Scholar Rock Holding Corp | 41.14M |